Antibody-drug conjugates are an innovative advancement in cancer therapy, combining monoclonal antibodies with potent cytotoxic drugs to deliver targeted treatment. This strategy enhances the therapeutic effects while reducing systemic toxicity, making antibody-drug conjugates a crucial breakthrough